Related Experiment Video
Updated: Aug 3, 2026

10:09
Capillary Force Lithography for Cardiac Tissue Engineering
Published on: June 10, 2014
12.4K
Biofabrication strategies for cardiac tissue engineering
Sargol Okhovatian1, Ramak Khosravi2, Erika Y Wang3
1Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.
Current Opinion in Biotechnology
|June 28, 2024
Summary
Biofabrication technologies are advancing cardiac models for high-throughput, cost-effective research. Improvements in size, resolution, and biocompatibility are key for sophisticated cardiac engineering and disease modeling.
Area of Science:
- Biomedical Engineering
- Tissue Engineering
- Cardiovascular Research
Background:
- Current biofabrication technologies offer potential for creating complex cardiac models.
- Key parameters for advanced cardiac models include size, printing resolution, biocompatibility, and ease of fabrication.
Purpose of the Study:
- To review recent advancements in cardiac engineering technologies.
- To discuss the translation of these models for in vivo and in vitro applications.
Main Methods:
- Review of microscaled organoids, heart-on-a-chip platforms, and in vitro ventricle models.
- Examination of larger cardiac patches and associated biofabrication techniques.
- Discussion of advancements facilitating model translation.
Main Results:
- Biofabrication enables high-throughput, cost-effective cardiac models.
- Various scales of cardiac models are being developed, from organoids to larger patches.
- Models show promise for drug testing and disease modeling.
Conclusions:
- Continued advancements in biofabrication are crucial for developing sophisticated cardiac models.
- These engineered cardiac models have significant potential for both in vitro research and in vivo therapeutic applications.
More Related Videos
Related Concept Videos
Transgenic Organisms
Overview
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

